McElearney Catherine, Fitzpatrick Carol, Farrell Niamh, King Mary, Lynch Bryan
Department of Psychiatry,University College Dublin.
The Children's,University Hospital,Temple St,Dublin 1,Ireland.
Ir J Psychol Med. 2005 Mar;22(1):5-9. doi: 10.1017/S0790966700008715.
The prescription of stimulant medication to children with attention deficit hyperactivity disorder remains topical. Few reports target children's views about taking long-term medication. The aim was to assess child and parent views of stimulant medication. To compare attitudes to medication between two groups of children, those with attention deficit hyperactivity disorder taking stimulant medication and those with epilepsy taking anti-epileptic medication.
Forty children (n = 40) with attention deficit hyperactivity disorder on stimulant medication, and 40 children (n = 40) with epilepsy on anti-epileptic medication formed the study population. A semi-structured interview was carried out with each child and parent. Each parent completed the Dosage and Side-effects Questionnaire and the Attitude to Medication Questionnaire. Each child completed the Attitude to Medication Questionnaire.
Sixty per cent of children (n = 24) with attention deficit hyperactivity disorder and 62.5% (n = 25) of those with epilepsy knew the name and purpose of their medication. Forty per cent (n = 16) of children in the stimulant group and 32.5% (n = 13) in the anti-epileptic group reported themselves as being non-compliant with medication. In both groups children reported positive aspects to taking medication. More children with epilepsy reported negative aspects. Only 32.5% (n = 13) of children with attention deficit hyperactivity disorder said that they would tell a friend about their medication, while 55% (n = 22) of the children with epilepsy indicated that they would do so. In both groups parents were better informed than their children were about the purpose of the medication. Parents of children with attention deficit hyperactivity disorder tended to be more positive about medication than their children and than the parents in the comparison group.
The majority of children and their parents express positive views about the stimulant medication. Children's views about medication compliance and side-effects should be sought, as they may differ significantly from those of their parents. Where parents have noticed positive changes, but children have not, this information can be used therapeutically to help children feel more in control of their behaviour.
给注意力缺陷多动障碍儿童开具兴奋性药物仍然是热门话题。很少有报告关注儿童对长期服药的看法。本研究旨在评估儿童和家长对兴奋性药物的看法。比较两组儿童对药物治疗的态度，一组是服用兴奋性药物的注意力缺陷多动障碍儿童，另一组是服用抗癫痫药物的癫痫儿童。
40名服用兴奋性药物的注意力缺陷多动障碍儿童和40名服用抗癫痫药物的癫痫儿童构成了研究群体。对每个儿童及其家长进行了半结构化访谈。每位家长完成了《剂量与副作用问卷》和《对药物治疗的态度问卷》。每个儿童完成了《对药物治疗的态度问卷》。
60%（24名）的注意力缺陷多动障碍儿童和62.5%（25名）的癫痫儿童知道他们所服药物的名称和用途。兴奋剂组40%（16名）的儿童和抗癫痫组32.5%（13名）的儿童报告自己不遵医嘱服药。两组儿童都报告了服药的积极方面。更多癫痫儿童报告了消极方面。只有32.5%（13名）的注意力缺陷多动障碍儿童表示会告诉朋友自己服药的事情，而55%（22名）的癫痫儿童表示会这样做。两组中，家长比孩子更了解药物的用途。注意力缺陷多动障碍儿童的家长对药物治疗往往比他们的孩子以及对照组的家长更积极。
大多数儿童及其家长对兴奋性药物表达了积极看法。应该了解儿童对服药依从性和副作用的看法，因为这些看法可能与他们父母的看法有很大差异。如果家长注意到了积极变化，但孩子没有，这些信息可用于治疗，帮助孩子更好地控制自己的行为。
